Prescription medication · Angiotensin II Receptor Blocker (ARB)
eprosartan
Also sold as Teveten. Eprosartan is used to treat high blood pressure (hypertension).
Data updated 2026-05-15
- 9
- InteractionsFew interactions
- Rx
- Availability
eprosartan (Teveten) is a prescription Angiotensin II Receptor Blocker (ARB). Eprosartan is used to treat high blood pressure (hypertension).
Eprosartan (Teveten) is a medicine that lowers high blood pressure. It can be used alone or with other blood pressure medicines.
Verify with FDA → · CMS NADAC pricing →
What it does
Eprosartan is used to treat high blood pressure (hypertension).
Common side effects
Viral infection, Injury, Fatigue
Key warnings
If you become pregnant, stop taking eprosartan right away.
The sections below are summarized in plain English from eprosartan's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Eprosartan belongs to a class of drugs called angiotensin II receptor blockers (ARBs). It works by blocking a substance in your body that tightens blood vessels. This helps blood vessels relax, which lowers blood pressure.
Serious Warnings
If you become pregnant, stop taking eprosartan right away. This medicine can cause serious harm or death to your unborn baby.
Known Drug Interactions
Drug Interactions Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. Do not co-administer aliskiren with eprosartan in patients with diabetes. Avoid use of aliskiren with eprosartan in patients with renal impairment (GFR < 60 mL/min).
Mechanism: Both drugs work on the same system to lower blood pressure, which can cause blood pressure to drop too low or harm the kidneys.
or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide).
Mechanism: These two drugs work together to lower blood pressure and have been shown to be safe when used at the same time.
Concomitant administration of eprosartan and warfarin had no effect on steady-state prothrombin time ratios (INR) in healthy volunteers. Eprosartan has been shown to have no effect on the pharmacokinetics of digoxin and the pharmacodynamics of warfarin and glyburide.
Mechanism: Eprosartan does not change how warfarin works or how it affects your blood's ability to clot.
have been safely used concomitantly with sustained-release calcium channel blockers (sustained-release nifedipine) with no clinically significant adverse interactions.
Mechanism: These two blood pressure medicines do not have a negative effect on each other when taken together.
Eprosartan is not metabolized by the cytochrome P450 system; eprosartan steady-state concentrations were not affected by concomitant administration of ketoconazole or fluconazole, potent inhibitors of CYP3A and 2C9, respectively. Because eprosartan is not metabolized by the cytochrome P450 system, inhibitors of CYP450 enzyme would not be expected to affect its metabolism, and ketoconazole and fluconazole, potent inhibitors of CYP3A and 2C9, respectively, have been shown to have no effect on eprosartan pharmacokinetics.
Mechanism: Ketoconazole blocks certain liver proteins, but eprosartan is not processed by those proteins, so its levels do not change.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I take eprosartan with other medications?
What should I do if I feel dizzy after taking eprosartan?
Can I drink alcohol while taking eprosartan?
Does eprosartan have any effect on my kidneys?
Can eprosartan cause allergic reactions?
How long do I need to take eprosartan?
Can I stop taking eprosartan if my blood pressure is under control?
Are there any foods I should avoid while taking eprosartan?
Will eprosartan cure my high blood pressure?
What if I have diabetes?
What are the common side effects of eprosartan?
Does eprosartan interact with other medications?
What drug class is eprosartan?
What pregnancy or breastfeeding source fields are listed for eprosartan?
Related Medications in Angiotensin II Receptor Blocker (ARB)
Other drugs grouped near eprosartan - same-class peers and common alternatives.
acebutolol
Sectral
Acebutolol is a medicine that helps lower blood pressure and control irregular heartbeats.
Compare with eprosartan →
aliskiren
Tekturna
Tekturna is a medicine used to treat high blood pressure.
Compare with eprosartan →
amiloride
Midamor
Amiloride is a water pill that helps your body hold onto potassium.
Compare with eprosartan →
amlodipine
Norvasc
Amlodipine (Norvasc) is a drug that lowers blood pressure and treats chest pain.
Compare with eprosartan →
amlodipine/benazepril
Lotrel
Lotrel is a combination medicine that contains amlodipine and benazepril.
Compare with eprosartan →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on eprosartan
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for eprosartan
The FDA label for eprosartan (sold under brand names such as Teveten) classifies it as a prescription-only medication in the Angiotensin II Receptor Blocker (ARB) class. Eprosartan is used to treat high blood pressure (hypertension). Official labeling lists 11 commonly reported side effects, including Viral infection, Injury, Fatigue.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 9 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: December 5, 2014
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages